
Leah H. Schlientz
Examiner (ID: 5396)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 804 |
| Issued Applications | 283 |
| Pending Applications | 116 |
| Abandoned Applications | 429 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16977562
[patent_doc_number] => 20210221799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => AGGREGATION-INDUCED EMISSION LUMINOGENS FOR PHOTODYNAMIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/248340
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 337
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248340 | Aggregation-induced emission luminogens for photodynamic therapy | Jan 20, 2021 | Issued |
Array
(
[id] => 16976254
[patent_doc_number] => 20210220491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => FLUORESCENCE IMAGING METHOD AND SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/150488
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150488 | FLUORESCENCE IMAGING METHOD AND SYSTEM | Jan 14, 2021 | Abandoned |
Array
(
[id] => 17020960
[patent_doc_number] => 20210244831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => POLYDOPAMINE DECORATED TOBACCO MOSAIC THERANOSTIC VIRUS NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/129490
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129490 | Polydopamine decorated tobacco mosaic theranostic virus nanoparticles | Dec 20, 2020 | Issued |
Array
(
[id] => 16776640
[patent_doc_number] => 20210113717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
[patent_app_type] => utility
[patent_app_number] => 17/126340
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126340 | MRI contrast agent including T1 contrast material coated on surface of nanoparticle support | Dec 17, 2020 | Issued |
Array
(
[id] => 18075977
[patent_doc_number] => 20220401589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => PRE-TARGETING IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/777182
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777182 | PRE-TARGETING IMAGING AGENTS | Dec 3, 2020 | Pending |
Array
(
[id] => 17126110
[patent_doc_number] => 20210300878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/111953
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111953 | CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING | Dec 3, 2020 | Abandoned |
Array
(
[id] => 16853590
[patent_doc_number] => 20210154335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => DYE AGGREGATES-CONTAINING NANOPARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/104859
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104859 | DYE AGGREGATES-CONTAINING NANOPARTICLES AND USES THEREOF | Nov 24, 2020 | Abandoned |
Array
(
[id] => 17154966
[patent_doc_number] => 20210316017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/103366
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103366 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER | Nov 23, 2020 | Abandoned |
Array
(
[id] => 18108146
[patent_doc_number] => 20230001026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT ADMINISTRATION OF RADIOTRACERS
[patent_app_type] => utility
[patent_app_number] => 17/778754
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778754 | PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT ADMINISTRATION OF RADIOTRACERS | Nov 19, 2020 | Pending |
Array
(
[id] => 16656115
[patent_doc_number] => 20210052751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Ultrasound Gel Composition
[patent_app_type] => utility
[patent_app_number] => 17/093155
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/093155 | Ultrasound Gel Composition | Nov 8, 2020 | Abandoned |
Array
(
[id] => 18056549
[patent_doc_number] => 20220387635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PET IMAGING OF CANCEROUS CELLS USING 18F-FLUOROACETATE
[patent_app_type] => utility
[patent_app_number] => 17/774136
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774136 | PET IMAGING OF CANCEROUS CELLS USING 18F-FLUOROACETATE | Nov 3, 2020 | Pending |
Array
(
[id] => 18019146
[patent_doc_number] => 20220370645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD, DEVICE AND MARKER SUBSTANCE KIT FOR MULTI-PARAMETRIC X-RAY FLUORESCENCE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/771460
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771460 | METHOD, DEVICE AND MARKER SUBSTANCE KIT FOR MULTI-PARAMETRIC X-RAY FLUORESCENCE IMAGING | Oct 22, 2020 | Pending |
Array
(
[id] => 18034734
[patent_doc_number] => 20220378949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/769693
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769693
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769693 | NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF | Oct 21, 2020 | Pending |
Array
(
[id] => 19125851
[patent_doc_number] => 20240131204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/768420
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768420 | Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer | Oct 8, 2020 | Pending |
Array
(
[id] => 16596484
[patent_doc_number] => 20210023015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COLOR-CODED AND SIZED LOADABLE POLYMERIC PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND METHODS OFPREPARING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/065319
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065319 | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same | Oct 6, 2020 | Issued |
Array
(
[id] => 18176931
[patent_doc_number] => 20230037660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS
[patent_app_type] => utility
[patent_app_number] => 17/764132
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764132 | METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS | Sep 30, 2020 | Abandoned |
Array
(
[id] => 18108147
[patent_doc_number] => 20230001027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METAL CHELATING AGENTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/764708
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764708 | METAL CHELATING AGENTS AND METHODS OF USING THE SAME | Sep 29, 2020 | Pending |
Array
(
[id] => 16710490
[patent_doc_number] => 20210077637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/060059
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060059 | PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof | Sep 29, 2020 | Abandoned |
Array
(
[id] => 20343121
[patent_doc_number] => 12466843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Gadolinium-based compound, method for producing same, and MRI contrast agent containing same
[patent_app_type] => utility
[patent_app_number] => 17/755143
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 916
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755143 | Gadolinium-based compound, method for producing same, and MRI contrast agent containing same | Sep 28, 2020 | Issued |
Array
(
[id] => 18091406
[patent_doc_number] => 20220409747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/761508
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761508
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761508 | FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES | Sep 16, 2020 | Pending |